JAZZ PHARMACEUTICALS, INC
Doing business as JAZZ PHARMACEUTICALS INC
- PALO ALTO, CA 94306-2100
- jazzpharma.com (company website, opens in a new tab)
- Corporate Entity (Not Tax Exempt)
- SAM expiring
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $4.7M
- Awards on record
- 54
- Contract vehicles
- 0
- Verified credentials
- 0
SAM.gov registration expires in 43 days
JAZZ PHARMACEUTICALS, INC’s registration expires on Dec 26, 2026. Renewal can take weeks; confirm it stays active through proposal submission and award.
View on SAM.gov (opens in a new tab)Learn more about SAM registration and the UEI
About JAZZ PHARMACEUTICALS, INC
- Headquarters
- PALO ALTO, CA 94306-2100
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEIH9AXCNRA5NE6
- CAGE4RTH5
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
- 36-month obligations
- $4.7M
- Awards on record
- 54
- Top funding agencies
- Department of Veterans Affairs
25 most recent of 54 awards
36C26027F0008
Recompete 6–12 mo: Potential end Sep 30, 2027 (10 months away)XYREM
Department of Veterans Affairs
- Obligated
- $106.3K
- Period of performance
- Oct 1, 2026 – Sep 30, 2027
36C26026F0012
Completed: Period of performance ended Sep 30, 2026PHARM - XYREM
Department of Veterans Affairs
- Obligated
- $133K
- Period of performance
- Oct 1, 2025 – Sep 30, 2026
36C26026F0013
Completed: Period of performance ended Sep 30, 2026PHARM - XYWAV
Department of Veterans Affairs
- Obligated
- $231.1K
- Period of performance
- Oct 1, 2025 – Sep 30, 2026
36C26026F0027
Completed: Period of performance ended Sep 30, 2026XYWAV 500MG/ML ORAL SOLUTION, AND XYREM 500MG/ML ORAL SOLUTION
Department of Veterans Affairs
- Obligated
- $0
- Period of performance
- Oct 1, 2025 – Sep 30, 2026
36C26025F0161
Completed: Period of performance ended Mar 9, 2026XYWAV
Department of Veterans Affairs
- Obligated
- $179.5K
- Period of performance
- Mar 9, 2025 – Mar 9, 2026
36C24526N0282
Completed: Period of performance ended Feb 4, 2026XYREM 500 MG
Department of Veterans Affairs
- Obligated
- $14.7K
- Period of performance
- Jan 31, 2026 – Feb 4, 2026
36C26026F0146
Completed: Period of performance ended Feb 1, 2026XYWAV 500MG/ML ORAL SOLN
Department of Veterans Affairs
- Obligated
- $397.9K
- Period of performance
- Feb 1, 2026 – Feb 1, 2026
36C26025F0178
Completed: Period of performance ended Jan 31, 2026BULK ORDER XYWAV
Department of Veterans Affairs
- Obligated
- $678.6K
- Period of performance
- Jun 1, 2025 – Jan 31, 2026
36C24526N0198
Completed: Period of performance ended Dec 29, 2025XYREM 500 MG
Department of Veterans Affairs
- Obligated
- $14.2K
- Period of performance
- Dec 23, 2025 – Dec 29, 2025
36C26025F0293
Completed: Period of performance ended Sep 30, 2025EMERGENCY ORDER XYREM SODIUM OXYBATE 500MG/ML SOLN, ORAL 180ML.
Department of Veterans Affairs
- Obligated
- $34.6K
- Period of performance
- Jun 12, 2025 – Sep 30, 2025
36C26025F0016
Completed: Period of performance ended Sep 30, 2025XYWAV BULK
Department of Veterans Affairs
- Obligated
- $206.1K
- Period of performance
- Oct 1, 2024 – Sep 30, 2025
36C26025F0025
Completed: Period of performance ended Sep 30, 2025XYWAV 500MG/ML ORAL SOLUTION (SOLN).
Department of Veterans Affairs
- Obligated
- $229K
- Period of performance
- Oct 1, 2024 – Sep 30, 2025
36C26025F0027
Completed: Period of performance ended May 31, 2025BULK PHARMACY XYWAV
Department of Veterans Affairs
- Obligated
- $526.1K
- Period of performance
- Dec 1, 2024 – May 31, 2025
36C26024F0282
Completed: Period of performance ended Mar 8, 2025XYWAV ORAL SOLUTION
Department of Veterans Affairs
- Obligated
- $147.1K
- Period of performance
- Mar 8, 2024 – Mar 8, 2025
36C26024F0189
Completed: Period of performance ended Dec 31, 2024XYWAV PHARMACEUTICAL
Department of Veterans Affairs
- Obligated
- $133K
- Period of performance
- Jan 24, 2024 – Dec 31, 2024
36C24525N0266
Completed: Period of performance ended Dec 24, 2024XYWAV 500 MG ORAL SOLUTION
Department of Veterans Affairs
- Obligated
- $10.2K
- Period of performance
- Dec 20, 2024 – Dec 24, 2024
36C24525N0244
Completed: Period of performance ended Dec 17, 2024XYWAV 500 MG ORAL SOLUTION
Department of Veterans Affairs
- Obligated
- $0
- Period of performance
- Dec 13, 2024 – Dec 17, 2024
36C24525N0229
Completed: Period of performance ended Dec 13, 2024XYWAV 500 MG ORAL SOLUTION
Department of Veterans Affairs
- Obligated
- $10.2K
- Period of performance
- Dec 11, 2024 – Dec 13, 2024
36C26024F0344
Completed: Period of performance ended Nov 30, 2024XYWAV BULK ORDER
Department of Veterans Affairs
- Obligated
- $468.9K
- Period of performance
- Jun 1, 2024 – Nov 30, 2024
36C24525N0197
Completed: Period of performance ended Nov 27, 2024XYWAV 500 MG ORAL SOLUTION
Department of Veterans Affairs
- Obligated
- $10.2K
- Period of performance
- Nov 22, 2024 – Nov 27, 2024
36C24525N0164
Completed: Period of performance ended Nov 15, 2024XYWAV 500 MG ORAL SOLUTION
Department of Veterans Affairs
- Obligated
- $10.2K
- Period of performance
- Nov 12, 2024 – Nov 15, 2024
36C24525N0138
Completed: Period of performance ended Oct 25, 2024XYWAV 500 MG ORAL SOLUTION
Department of Veterans Affairs
- Obligated
- $10.2K
- Period of performance
- Oct 24, 2024 – Oct 25, 2024
36C24525N0121
Completed: Period of performance ended Oct 15, 2024XYWAV 500 MG ORAL SOLUTION
Department of Veterans Affairs
- Obligated
- $10.2K
- Period of performance
- Oct 10, 2024 – Oct 15, 2024
36C24525N0122
Completed: Period of performance ended Oct 15, 2024XYWAV 500 MG ORAL SOLUTION
Department of Veterans Affairs
- Obligated
- $10.2K
- Period of performance
- Oct 10, 2024 – Oct 15, 2024
36C26024F0151
Completed: Period of performance ended Oct 3, 2024XYWAV ORAL SOLUTION
Department of Veterans Affairs
- Obligated
- $163.7K
- Period of performance
- Jan 4, 2024 – Oct 3, 2024
| Award | Agency | NAICS · PSC | Obligated | Period of performance | Recompete |
|---|---|---|---|---|---|
36C26027F0008 under 36F79719D0205 XYREM | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $106.3K | Oct 1, 2026 – Sep 30, 2027 | Recompete 6–12 mo: Potential end Sep 30, 2027 (10 months away)AI brief for award 36C26027F0008Bid team for the recompete of award 36C26027F0008 |
36C26026F0012 under 36F79719D0205 PHARM - XYREM | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $133K | Oct 1, 2025 – Sep 30, 2026 | Completed: Period of performance ended Sep 30, 2026 |
36C26026F0013 under 36F79719D0205 PHARM - XYWAV | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $231.1K | Oct 1, 2025 – Sep 30, 2026 | Completed: Period of performance ended Sep 30, 2026 |
36C26026F0027 under 36F79719D0205 XYWAV 500MG/ML ORAL SOLUTION, AND XYREM 500MG/ML ORAL SOLUTION | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $0 | Oct 1, 2025 – Sep 30, 2026 | Completed: Period of performance ended Sep 30, 2026 |
36C26025F0161 under 36F79719D0205 XYWAV | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $179.5K | Mar 9, 2025 – Mar 9, 2026 | Completed: Period of performance ended Mar 9, 2026 |
36C24526N0282 under 36F79719D0205 XYREM 500 MG | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $14.7K | Jan 31, 2026 – Feb 4, 2026 | Completed: Period of performance ended Feb 4, 2026 |
36C26026F0146 under 36F79719D0205 XYWAV 500MG/ML ORAL SOLN | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $397.9K | Feb 1, 2026 – Feb 1, 2026 | Completed: Period of performance ended Feb 1, 2026 |
36C26025F0178 under 36F79719D0205 BULK ORDER XYWAV | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $678.6K | Jun 1, 2025 – Jan 31, 2026 | Completed: Period of performance ended Jan 31, 2026 |
36C24526N0198 under 36F79719D0205 XYREM 500 MG | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $14.2K | Dec 23, 2025 – Dec 29, 2025 | Completed: Period of performance ended Dec 29, 2025 |
36C26025F0293 under 36F79719D0205 EMERGENCY ORDER XYREM SODIUM OXYBATE 500MG/ML SOLN, ORAL 180ML. | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $34.6K | Jun 12, 2025 – Sep 30, 2025 | Completed: Period of performance ended Sep 30, 2025 |
36C26025F0016 under 36F79719D0205 XYWAV BULK | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $206.1K | Oct 1, 2024 – Sep 30, 2025 | Completed: Period of performance ended Sep 30, 2025 |
36C26025F0025 under 36F79719D0205 XYWAV 500MG/ML ORAL SOLUTION (SOLN). | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $229K | Oct 1, 2024 – Sep 30, 2025 | Completed: Period of performance ended Sep 30, 2025 |
36C26025F0027 under 36F79719D0205 BULK PHARMACY XYWAV | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $526.1K | Dec 1, 2024 – May 31, 2025 | Completed: Period of performance ended May 31, 2025 |
36C26024F0282 under 36F79719D0205 XYWAV ORAL SOLUTION | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $147.1K | Mar 8, 2024 – Mar 8, 2025 | Completed: Period of performance ended Mar 8, 2025 |
36C26024F0189 under 36F79719D0205 XYWAV PHARMACEUTICAL | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $133K | Jan 24, 2024 – Dec 31, 2024 | Completed: Period of performance ended Dec 31, 2024 |
36C24525N0266 under 36F79719D0205 XYWAV 500 MG ORAL SOLUTION | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $10.2K | Dec 20, 2024 – Dec 24, 2024 | Completed: Period of performance ended Dec 24, 2024 |
36C24525N0244 under 36F79719D0205 XYWAV 500 MG ORAL SOLUTION | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $0 | Dec 13, 2024 – Dec 17, 2024 | Completed: Period of performance ended Dec 17, 2024 |
36C24525N0229 under 36F79719D0205 XYWAV 500 MG ORAL SOLUTION | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $10.2K | Dec 11, 2024 – Dec 13, 2024 | Completed: Period of performance ended Dec 13, 2024 |
36C26024F0344 under 36F79719D0205 XYWAV BULK ORDER | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $468.9K | Jun 1, 2024 – Nov 30, 2024 | Completed: Period of performance ended Nov 30, 2024 |
36C24525N0197 under 36F79719D0205 XYWAV 500 MG ORAL SOLUTION | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $10.2K | Nov 22, 2024 – Nov 27, 2024 | Completed: Period of performance ended Nov 27, 2024 |
36C24525N0164 under 36F79719D0205 XYWAV 500 MG ORAL SOLUTION | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $10.2K | Nov 12, 2024 – Nov 15, 2024 | Completed: Period of performance ended Nov 15, 2024 |
36C24525N0138 under 36F79719D0205 XYWAV 500 MG ORAL SOLUTION | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $10.2K | Oct 24, 2024 – Oct 25, 2024 | Completed: Period of performance ended Oct 25, 2024 |
36C24525N0121 under 36F79719D0205 XYWAV 500 MG ORAL SOLUTION | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $10.2K | Oct 10, 2024 – Oct 15, 2024 | Completed: Period of performance ended Oct 15, 2024 |
36C24525N0122 under 36F79719D0205 XYWAV 500 MG ORAL SOLUTION | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $10.2K | Oct 10, 2024 – Oct 15, 2024 | Completed: Period of performance ended Oct 15, 2024 |
36C26024F0151 under 36F79719D0205 XYWAV ORAL SOLUTION | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $163.7K | Jan 4, 2024 – Oct 3, 2024 | Completed: Period of performance ended Oct 3, 2024 |
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
No SBIR/STTR awards on record
Source: SBIR.gov award records (opens in a new tab) · sync date not recorded
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 325412Pharmaceutical Preparation ManufacturingPrimary
SAM.gov does not report this entity as small under any listed NAICS code.
Socio-economic status
No socio-economic certifications reported in SAM.gov.
Product & service codes (PSC)
- 6505DRUGS AND BIOLOGICALS
PSC names from the Acquisition.gov PSC Manual (opens in a new tab) (April 2025 edition), checked Nov 12, 2026.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with JAZZ PHARMACEUTICALS, INC?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.